Trials / Completed
CompletedNCT02930031
Redox Status and Immune Function
Evidence of a Redox-dependent Regulation of Immune Responses to Exercise-Induced Inflammation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- National and Kapodistrian University of Athens · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
In this investigation the investigators utilized N-acetylcysteine (NAC) supplementation to enhance reduced glutathione (GSH) stores during an 8-day recovery period from a strenuous eccentric exercise protocol in order to test the hypotheses: i) redox status perturbations in skeletal muscle are pivotal for the immune responses and ii) antioxidant supplementation may alter immune cell responses following exercise-induced muscle microtrauma.
Detailed description
The major thiol-disulfide couple of GSH and oxidized glutathione (GSSG) is a crucial regulator of the main transcriptional pathways regulating aseptic inflammation and recovery of skeletal muscle following aseptic injury. Antioxidant supplementation may hamper exercise-induced inflammatory responses. The objective was to examine how thiol-based antioxidant supplementation affects immune mobilization following exercise-induced skeletal muscle microtrauma. In a two-trial, double-blind, crossover, repeated measures design, 10 young men received either placebo or NAC (20 mg/kg/day) immediately after a muscle-damaging exercise protocol (300 eccentric contractions) and for eight consecutive days. Blood sampling and performance assessment were performed pre-exercise, 2h post-exercise and daily for 8 consecutive days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | n-acetylcysteine | 20 mg//kg/day, orally, daily for eight days following exercise |
| DIETARY_SUPPLEMENT | Placebo | 500 mL orally, daily for eight days following exercise |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-02-01
- Completion
- 2016-03-01
- First posted
- 2016-10-11
- Last updated
- 2016-10-11
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT02930031. Inclusion in this directory is not an endorsement.